Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Blinded, Multicenter Study to Evaluate the Efficacy and Safety of Varisolve Polidocanol Endovenous Microfoam (PEM) 0.5% and 1% Compared to Vehicle for the Treatment on Saphenofemoral Junction (SFJ) Incompetence "VANISH-2"

NCT01231373 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT01231373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01231373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Blinded, Multicenter Study to Evaluate the Efficacy and Safety of Varisolve Polidocanol Endovenous Microfoam (PEM) 0.5% and 1% Compared to Vehicle for the Treatment on Saphenofemoral Junction (SFJ) Incompetence "VANISH-2"
Lead sponsor
Boston Scientific Corporation
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2010
Completion date
August 31, 2014
Enrollment
235 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

varicose veins